Erste Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Hold |
44,700
| – | – | ﹤0.01% | 817 |
|
|
2025
Q1 | $339K | Hold |
44,700
| – | – | ﹤0.01% | 452 |
|
|
2024
Q4 | $525K | Hold |
44,700
| – | – | 0.01% | 437 |
|
|
2024
Q3 | $825K | Hold |
44,700
| – | – | 0.01% | 395 |
|
|
2024
Q2 | $958K | Hold |
44,700
| – | – | 0.01% | 376 |
|
|
2024
Q1 | $1.22M | Buy |
44,700
+28,000
| +168% | +$763K | 0.02% | 354 |
|
|
2023
Q4 | $516K | Hold |
16,700
| – | – | 0.01% | 420 |
|
|
2023
Q3 | $346K | Hold |
16,700
| – | – | 0.01% | 446 |
|
|
2023
Q2 | $335K | Hold |
16,700
| – | – | 0.01% | 457 |
|
|
2023
Q1 | $272K | Hold |
16,700
| – | – | 0.01% | 476 |
|
|
2022
Q4 | $326K | Hold |
16,700
| – | – | 0.01% | 454 |
|
|
2022
Q3 | $234K | Hold |
16,700
| – | – | 0.01% | 486 |
|
|
2022
Q2 | $218K | Hold |
16,700
| – | – | ﹤0.01% | 507 |
|
|
2022
Q1 | $266K | Hold |
16,700
| – | – | 0.01% | 491 |
|
|
2021
Q4 | $379K | Hold |
16,700
| – | – | 0.01% | 446 |
|
|
2021
Q3 | $500K | Hold |
16,700
| – | – | 0.01% | 409 |
|
|
2021
Q2 | $724K | Hold |
16,700
| – | – | 0.01% | 375 |
|
|
2021
Q1 | $724K | Hold |
16,700
| – | – | 0.02% | 355 |
|
|
2020
Q4 | $933K | Buy |
+16,700
| New | +$933K | 0.03% | 344 |
|